FYERS
Home
/
Stocks
/
Profit Loss
/
Anthem Biosciences Profit & Loss

Anthem Biosciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
₹418 Cr₹611 Cr₹423 Cr₹550 Cr₹540 Cr₹483 Cr₹498 Cr₹525 Cr₹339 Cr
₹25 Cr₹51 Cr₹34 Cr₹48 Cr₹23 Cr₹14 Cr₹24 Cr₹28 Cr₹19 Cr
₹443 Cr₹662 Cr₹457 Cr₹598 Cr₹563 Cr₹497 Cr₹522 Cr₹553 Cr₹358 Cr
₹298 Cr₹383 Cr₹300 Cr₹366 Cr₹375 Cr₹318 Cr₹359 Cr₹350 Cr₹236 Cr
₹175 Cr₹318 Cr₹191 Cr₹266 Cr₹214 Cr₹209 Cr₹184 Cr₹223 Cr₹140 Cr
₹89 L₹2 Cr₹35 L₹3 Cr₹2 Cr₹52 L₹3 Cr₹4 Cr₹4 Cr
₹145 Cr₹278 Cr₹130 Cr₹230 Cr₹186 Cr₹178 Cr₹161 Cr₹200 Cr₹118 Cr
₹120 Cr₹190 Cr₹93 Cr₹173 Cr₹136 Cr₹83 Cr₹124 Cr₹162 Cr₹82 Cr

Share Price Live Stats

Open (₹)970.00
Volume (₹)7.16 L
High (₹)973.50
Upper Circuit1,140.80
Low (₹)926.80
Lower Circuit760.60
Prev Close950.70
52W High (₹)973.50
Price934.90
52W Low (₹)579.15

Share Market Cap & Key Ratios Overview

M.Cap (₹)53498.40 Cr
Div. Yield (%)0.21
PE Ratio92.89
Debt to Equity0.02
Price to Book12.25
Book Value53.57
EPS (TTM)10.22
Face Value2.00
ROE (%)21.98

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ANTHEMNSE
LTP
1W Low
1W High
Market cap (₹)
1901.1-18.9 (-0.98%)
1896.80
1984.80
4,56,833Cr
9158.5-80.5 (-0.87%)
9087
9467
2,45,426Cr
4837-213 (-4.22%)
4823
5066
1,87,320Cr
1129.2-61.8 (-5.19%)
1125.10
1187
1,13,217Cr
1380-43.5 (-3.06%)
1376
1426.10
1,12,212Cr
1846.2-92.3 (-4.76%)
1811.70
1949
1,01,155Cr
2112.5-59 (-2.72%)
2107.20
2192
97,626Cr
2331.7-51.2 (-2.15%)
2327.30
2419.20
96,859Cr
1157.4-20.6 (-1.75%)
1154.40
1179.90
96,406Cr
1651.5+6.2 (0.38%)
1622.60
1717
93,614Cr
934.9+34.8 (3.87%)
888
973.50
53,498Cr

Key Highlights of Anthem Biosciences Ltd’s P&L

In 2026-03-31, Anthem Biosciences Ltd reported total revenue of ₹2280.11Cr, compared with ₹1930.28Cr in 2025-03-31, reflecting Anthem Biosciences Ltd turnover.

Depreciation was ₹134.07Cr and finance costs were ₹7.05Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹824.24Cr in 2026-03-31 as compared to ₹656.87Cr in 2025-03-31.

Net Profit (PAT) was ₹591.79Cr in 2026-03-31 compared with ₹451.26Cr in 2025-03-31.

Earnings per share (EPS) were ₹10.54 in 2026-03-31, compared with ₹8.07 in 2025-03-31.